NPPA clarifies that the Hospitals / Nursing Homes / Clinics are allowed to add trade margins on orthopaedic knee implants as per the prescribed rates by comtideging1971 | Sep 6, 2019 | OPS, Pharmaceuticals, statesIn a recent notification dated 13th August 2019 the National Pharmaceutical Pricing Authority... Read More
‘Marketer’ of Drugs will soon be responsible for the quality of drugs as well as other regulatory compliances followed by manufacturer/s; Amendment proposed to the Drugs and Cosmetics Rules by Lexplosion | Jun 26, 2019 | OPS, Pharmaceuticals, statesIn a Notification dated 24th June, 2019, the Ministry of Health and Family Welfare (“Ministry”)... Read More
BIS rolls out new IS standard for Medical Devices; Implementing new IS standards are expected to make Organizations more compliant with the essential principles of Safety and Performance / Quality Management System requirements by Lexplosion | Jun 19, 2019 | Healthcare, OPS, Pharmaceuticals, statesThe Bureau of Indian Standards (“BIS”) has published a new standard IS 23485 Medical Devices –... Read More
CDSCO releases Form for reporting Medical Devices Adverse Event ; designed to be used voluntarily by Manufacturer / Importer / Distributor of Medical Devices, Healthcare Professionals having knowledge of such adverse events by Lexplosion | Jun 11, 2019 | Healthcare, OPS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization has, recently released a Form for... Read More
CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices for the month of April, 2019 by Lexplosion | May 16, 2019 | OPS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization (“CDSCO”) in their official website has published... Read More
CDSCO directs applicants to upload applications through SUGAM Portal as per the New Drugs and Clinical Trial Rules, 2019 by Lexplosion | Apr 13, 2019 | OPS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization, 2019 has released a circular dated 10th April,... Read More
